P4-ML Information

P4ML is a precision health and life sciences company advancing predictive, preventive, personalized, and participatory (P4) healthcare at global scale. We integrate Single-Cell Omics, mass spectrometry, and AI-driven analytics to generate deep biological insights—enabling earlier disease detection, more accurate risk stratification, and the development of targeted therapeutics. Our approach shifts healthcare systems from reactive treatment models to proactive, data-driven care. At the core of our platform is the OMICAssist™ study, a longitudinal population health initiative designed to unlock high-resolution human health data across diverse cohorts. This enables governments, healthcare providers, and industry partners to improve clinical outcomes, reduce costs, and accelerate innovation in drug discovery and development. P4ML operates across USA, Europe and the Middle East, working closely with leading healthcare institutions, research organisations, and government bodies to build federated, trusted data environments that support scalable precision medicine. Beyond clinical applications, we are advancing innovation in space-enabled life sciences, protein crystallization, longevity research, and environmental health monitoring. Our work also extends into elite performance and recovery science through data-driven insights. By combining cutting-edge science with real-world deployment, P4ML is redefining how health systems understand, predict, and manage disease—delivering smarter, more sustainable healthcare solutions for the future. Smart Science for a Healthier Future.